Bio Business

» pharma, cancer, biotech and genetics & genomics

Most Recent

With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.

0 Comments

image: Flux and Uncertainty in the CRISPR Patent Landscape

Flux and Uncertainty in the CRISPR Patent Landscape

By Aggie Mika | October 1, 2017

The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.

0 Comments

image: Learning from Iceland’s Model for Genetic Research

Learning from Iceland’s Model for Genetic Research

By Catherine Offord | June 1, 2017

The Scandinavian island’s unique combination of genetic homogeneity, genealogical tradition, and high participation in research make it a prime location for discovery and validation of drug targets.

1 Comment

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By Catherine Offord | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By Catherine Offord | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

image: The Growth of Iowa Biotech

The Growth of Iowa Biotech

By Jenny Rood | August 1, 2016

The state’s industry draws inspiration from medicine as well as agriculture.

1 Comment

image: Do Patents Promote or Stall Innovation?

Do Patents Promote or Stall Innovation?

By Catherine Offord | June 1, 2016

A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.

3 Comments

image: Banking on Blood Tests

Banking on Blood Tests

By Jyoti Madhusoodanan | April 1, 2016

How close are liquid biopsies to replacing current diagnostics?

1 Comment

image: The Sounds of Silence

The Sounds of Silence

By Jenny Rood | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

4 Comments

image: The CAR T-Cell Race

The CAR T-Cell Race

By Vicki Brower | April 1, 2015

Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.

2 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Probiotics Prevent Cholera in Animal Models